Fulgent Genetics (FLGT) Total Debt (2020 - 2026)

Fulgent Genetics (FLGT) has 7 years of Total Debt data on file, last reported at $32.1 million in Q1 2026.

• Quarterly Total Debt rose 8.24% year-over-year to $32.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.1 million (up 8.24% YoY) and the FY2025 annual result came in at $30.1 million, changed 0.0% from the prior year.
• Total Debt grew to $32.1 million in Q1 2026 per FLGT's latest filing, from $30.1 million in the prior quarter.
• The five-year high for Total Debt was $32.1 million in Q1 2026, with the low at $14.3 million in Q4 2022.
• Average Total Debt over 5 years is $24.5 million, with a median of $29.0 million recorded in 2022.
• Year-over-year, Total Debt surged 347.38% in 2022 and sank 50.07% in 2023.
• Fulgent Genetics' Total Debt stood at $14.3 million in 2022, then jumped by 79.88% to $25.7 million in 2023, then gained by 17.3% to $30.1 million in 2024, then changed by 0.0% to $30.1 million in 2025, then grew by 6.62% to $32.1 million in 2026.
• Business Quant data shows FLGT's Total Debt at $32.1 million in Q1 2026, $30.1 million in Q4 2025, and $30.5 million in Q3 2025.